You are here: Industry Insights > Pfizer

News List

Financial Report: Pfizer contractpharma
May 03, 2017
Innovative Health sales were $7.4 billion in the quarter, up 5% driven by key brands including Ibrance and Eliquis, the addition of Xtandi revenues in the U.S. resulting from the September 2016 acquisition of Medivation...
InSphero, Pfizer to Develop Assays for DILI contractpharma
April 28, 2017
Will use InSphero 3D InSight to predict mechanisms that cause drug-induced liver injury
Domain Therapeutics and Pfizer Enter into Collaboration Agreement on bioSensAll americanpharmaceuticalreview
April 27, 2017
Domain Therapeutics announced a collaboration agreement with Pfizer aimed at assessing the impact of mutations on different signaling pathways engaged by G protein-coupled receptors (GPCRs).
Pfizer’s Phase III study to treat hospital-acquired pneumonia a success europeanpharmaceuticalreview
April 26, 2017
Positive results of Pfizer‘s REPROVE study showed that patients diagnosed with hospital-acquired pneumonia (HAP)...
Pfizer unveils ATLAS, an Interactive, website that provides global antibiotic resistance surveillanc cphi-online
April 25, 2017
Website can help inform global health strategies to mitigate the threat of antimicrobial resistance.
How Pfizer Inc. Makes Most of Its Money foxbusiness
April 18, 2017
Pfizer is organized into two business segments. The innovative health segment develops and markets prescription drugs...
HitGen and Pfizer Enter Research Collaboration and License Agreement to Build and Screen Novel DNA-E en-cphi.cn
April 17, 2017
Chengdu, China, April 17th, 2017, HitGen Ltd. has entered into a multi-year research collaboration and license agreement with Pfizer Inc. to build and screen novel DNA-encoded libraries (DELs) in order to potentially discover unique small molecule leads t
Pfizer's Prevnar conundrum: How to convince ‘invincible’ baby boomers they need a shot? fiercepharma
April 12, 2017
When Pfizer was gearing up to launch Prevnar 13 in adults age 50 and over, it faced a few unique challenges.
Pfizer Men B shot Trumenba wins EU committee's backing fiercepharma
March 31, 2017
Even as Pfizer’s vaccines outfit suffers a painful slowdown of its vaccine powerhouse Prevnar 13, the group may soon get a boost from another shot in Europe.
XELJANZ® (tofacitinib citrate) receives marketing authorisation in the European Union for the treatm worldpharmanews
March 28, 2017
Pfizer Inc. (NYSE:PFE) announced that the European Commission (EC) has approved XELJANZ® (tofacitinib citrate) 5 mg twice daily (BID) oral tablets in combination with methotrexate (MTX) for the treatment of moderate to severe active rheumatoid arthritis (

Previous page 1 2 3 4 5 6 7 8 9 10 ... 83 84 Next page